Transmission of human mtDNA heteroplasmy in the Genome of the Netherlands families:support for a variable-size bottleneck by Li, Mingkun et al.
  
 University of Groningen
Transmission of human mtDNA heteroplasmy in the Genome of the Netherlands families
Li, Mingkun; Rothwell, Rebecca; Vermaat, Martijn; Wachsmuth, Manja; Schroeder, Roland;






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Li, M., Rothwell, R., Vermaat, M., Wachsmuth, M., Schroeder, R., Laros, J. F. J., ... Genome Netherlands
Consortium (2016). Transmission of human mtDNA heteroplasmy in the Genome of the Netherlands
families: support for a variable-size bottleneck. Genome Research, 26(4), 417-426.
https://doi.org/10.1101/gr.203216.115
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Transmission of human mtDNA heteroplasmy
in the Genome of the Netherlands families:
support for a variable-size bottleneck
Mingkun Li,1,2 Rebecca Rothwell,3 Martijn Vermaat,4 Manja Wachsmuth,1
Roland Schröder,1 Jeroen F.J. Laros,4 Mannis van Oven,5 Paul I.W. de Bakker,6,7
Jasper A. Bovenberg,8 Cornelia M. van Duijn,9 Gert-Jan B. van Ommen,10
P. Eline Slagboom,11 Morris A. Swertz,12,13 Cisca Wijmenga,12,13 Genome of the
Netherlands Consortium,16 Manfred Kayser,5 Dorret I. Boomsma,14
Sebastian Zöllner,3,15 Peter de Knijff,11 and Mark Stoneking1
1Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, 04103 Leipzig, Germany; 2Fondation
Mérieux, 69002 Lyon, France; 3Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor,
Michigan 48109, USA; 4Leiden Genome Technology Center, Department of Human Genetics, Leiden University Medical Center,
Leiden 2300 RC, The Netherlands; 5Department of Genetic Identification, Erasmus MC University Medical Center Rotterdam,
Rotterdam 3000 CA, The Netherlands; 6Department of Medical Genetics, Center for Molecular Medicine, University Medical Center
Utrecht, Utrecht 3584 CG, The Netherlands; 7Department of Epidemiology, Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht 3584 CG, The Netherlands; 8Department of Biological Psychology, VU University
Amsterdam, Amsterdam 1081 BT, The Netherlands; 9Legal Pathways Institute for Health and Bio Law, Aerdenhout 2111, The
Netherlands; 10Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam 3000 CA, The
Netherlands; 11Department of Human Genetics, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; 12Section of
Molecular Epidemiology, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden 2300 RC, The
Netherlands; 13Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen 9700 RB,
The Netherlands; 14Genomics Coordination Center, University Medical Center Groningen, University of Groningen, Groningen
9700 RB, The Netherlands; 15Department of Psychiatry, University of Michigan, Ann Arbor, Michigan 48109, USA
Although previous studies have documented a bottleneck in the transmission of mtDNA genomes from mothers to off-
spring, several aspects remain unclear, including the size and nature of the bottleneck. Here, we analyze the dynamics of
mtDNA heteroplasmy transmission in the Genomes of the Netherlands (GoNL) data, which consists of complete
mtDNA genome sequences from 228 trios, eight dizygotic (DZ) twin quartets, and 10 monozygotic (MZ) twin quartets.
Using a minor allele frequency (MAF) threshold of 2%, we identified 189 heteroplasmies in the trio mothers, of which
59% were transmitted to offspring, and 159 heteroplasmies in the trio offspring, of which 70% were inherited from the
mothers. MZ twin pairs exhibited greater similarity in MAF at heteroplasmic sites than DZ twin pairs, suggesting that the
heteroplasmyMAF in the oocyte is the major determinant of the heteroplasmyMAF in the offspring. We used a likelihood
method to estimate the effective number of mtDNA genomes transmitted to offspring under different bottleneck models; a
variable bottleneck size model provided the best fit to the data, with an estimated mean of nine individual mtDNA genomes
transmitted. We also found evidence for negative selection during transmission against novel heteroplasmies (in which the
minor allele has never been observed in polymorphism data). These novel heteroplasmies are enhanced for tRNA and
rRNA genes, and mutations associated with mtDNA diseases frequently occur in these genes. Our results thus suggest
that the female germ line is able to recognize and select against deleterious heteroplasmies.
[Supplemental material is available for this article.]
Heteroplasmy (intra-individual variation) in mitochondrial DNA
(mtDNA) plays an important role in mtDNA-related diseases and
has also been implicated in aging and cancer (Greaves et al.
2012; Wallace 2012; Chinnery and Hudson 2013; Lombès et al.
2014). Most mtDNA mutations that cause diseases due to defects
in mitochondrial function exist as heteroplasmies and only cause
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disease symptoms when the frequency of the mutant allele ex-
ceeds a particular threshold (Wallace and Chalkia 2013). Below
this threshold, individuals are asymptomatic, presumably because
there are sufficient functional mitochondria for normal metab-
olism. Changes in the frequency of pathogenic mutations during
the transmission of heteroplasmies from mothers to offspring
can thus play an important role in the disease risk of the offspring.
However, most of our knowledge concerning the dynamics of het-
eroplasmy transmission comes from studies of pathogenic muta-
tions (Monnot et al. 2011; Shen et al. 2012; de Laat et al. 2013;
Wallace and Chalkia 2013), which in blood have been shown
to decrease over time and hence may not accurately reflect the
overall level of such pathogenic mutations within an individual
(Poulton and Morten 1993; ‘t Hart et al. 1996; Rahman et al.
2001; Rajasimha et al. 2008).Mousemodels have also beenutilized
(Cree et al. 2008; Fan et al. 2008; Freyer et al. 2012; Ross et al. 2013),
but to date, there have been only a few studies of normal patterns
of heteroplasmy transmission in humans (Sekiguchi et al. 2003;
Goto et al. 2011; Sondheimer et al. 2011; Guo et al. 2013;
Rebolledo-Jaramillo et al. 2014), including studies of oocytes and
placenta (Marchington et al. 1997, 2002; Jacobs et al. 2007), and
several questions remain.
For example, although it is clear that a bottleneck occurs dur-
ing the transmission of mtDNA genomes from mothers to off-
spring, the size of the bottleneck remains a contentious issue.
Previous estimates of the effective number of transmitted mtDNA
genomes range widely, from eight to 200 (Brown et al. 2001; Guo
et al. 2013; Rebolledo-Jaramillo et al. 2014). However, all previous
studies have assumed a constant size for the bottleneck across indi-
viduals; the effect of allowing the bottleneck size to vary among
individuals has not been investigated. Moreover, it has been sug-
gested thatmtDNA genomesmay not behave as independent enti-
ties but instead are organized into discrete units called “nucleoids,”
each of which contains 5–10 mtDNA genomes (Jacobs et al. 2000;
Cao et al. 2007; Khrapko 2008), although recently it has been
suggested that the number may be much smaller, on the order of
one mtDNA genome per nucleoid (Kukat et al. 2011). Each nucle-
oid is thought to be homoplasmic for mtDNA genome sequences;
thus, mtDNA heteroplasmy at the cellular level would reflect
nucleoids that are homoplasmic for different sequence variants.
Nucleoid structures within cells have been studiedmicroscopically
and biochemically (Bogenhagen 2012), and nucleoid-based mod-
els have been found to provide a better fit to the segregation of
heteroplasmic mtDNA genomes in cell lines than do simple bot-
tleneck models in some studies (Cao et al. 2007; Khrapko 2008),
but not in others (Cree et al. 2008). However, to date, nucleoid-
based models have not been investigated in the transmission of
mtDNA heteroplasmy from mothers to offspring.
Another issue is the degree to which negative (or purifying)
selection may act on deleterious variants during the transmission
ofmtDNAheteroplasmy. There are conflicting results and views as
to whether changes in the frequency of a heteroplasmic mutation
from mother to offspring are governed solely by genetic drift,
or whether there is an additional role for negative (purifying) selec-
tion (Jenuth et al. 1997; Durham et al. 2006; Stewart et al. 2008a,b;
Wonnapinij et al. 2008; Wallace and Chalkia 2013; Rebolledo-
Jaramillo et al. 2014). Negative selection during heteroplasmy
transmission, as evidenced by a decrease in the frequency of pre-
sumably deleterious heteroplasmic variants in offspring compared
to mothers, must operate on the female germ line and/or early in
development after fertilization, and hence differs fromnegative se-
lection operating on homoplasmic variants that reduce viability or
fertility (Holt et al. 2014). The opportunities for, and extent of,
such negative selection during heteroplasmy transmission in hu-
mans remain largely unknown.
Here, we utilize the Genomes of the Netherlands (GoNL)
project (Boomsma et al. 2014; Genome of the Netherlands
Consortium 2014), consisting of whole-genome sequence data
from blood samples from 250 families, to carry out the largest
study to date (to our knowledge) of the dynamics of heteroplasmy
transmission across the entiremtDNA genome.We utilize the data
on changes in minor allele frequency (MAF) from mothers to off-
spring at heteroplasmic sites to compare different models for the
inheritance of mtDNA genomes, and we analyze the data for evi-
dence of negative selection during heteroplasmy transmission.
Results
Heteroplasmy characteristics
After quality filtering, there were data from 246 families represent-
ing 228 trios, eight DZ twin quartets, and 10 MZ twin quartets (to-
tal of 254 independent transmissions of mtDNA from mother to
offspring, assuming independent transmissions of mtDNA to the
DZ twins), sequenced to an average mtDNA coverage of approxi-
mately 1200× (Supplemental Table S1; Supplemental Fig. S1).
We first used strict criteria, requiring all heteroplasmies in each
individual to pass the quality control measures (including a mini-
mum minor allele frequency [MAF] of 2%) to identify heteroplas-
mies. These quality control measures also include criteria for
detecting contamination and the potential influence of nuclear in-
serts of mtDNA (NUMTs), as discussed in detail elsewhere (Li et al.
2012; Li and Stoneking 2012). We then called additional hetero-
plasmies in mothers or offspring if the same two alleles were de-
tected in both (regardless of frequency) and if the heteroplasmy
at that position in either the mother or the offspring had passed
the quality control measures. With these criteria, we identified
189 heteroplasmies at 163 positions in the 228 trio mothers and
159 heteroplasmies at 137 positions in the 228 trio offspring
(Table 1; Supplemental Table S1); the heteroplasmy data for the
twin quartets are considered separately (Supplemental Tables S2,
S3). A list of all of the heteroplasmies identified and associated
MAF can be found in Supplemental Data Set S1. We also analyzed
a subset of these heteroplasmies (Supplemental Tables S4, S5) with
a different detectionmethod, namely droplet digital PCR (ddPCR),
and found a very high and significant correlation (Pearson’s
correlation = 0.998, P < 0.00001) between MAF estimated from se-
quencing versus MAF estimated from ddPCR (Supplemental
Fig. S2). Even for low frequency heteroplasmies (MAF < 0.05), the









Mothers 228 189 0.109
Nontransmitted 77 (41%) 0.072
Transmitted 112 (59%) 0.134
Offspring 228 159 0.120
Noninherited 47 (30%) 0.077
Inherited 112 (70%) 0.137
Total 456 348 0.107
(MAF) Minor allele frequency; the data for MZ and DZ twins are in
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correlation is still quite high (Pearson’s correlation = 0.890, P <
0.00001). Thus, the heteroplasmies identified by our criteria in
the sequencing data are reproducible by a different method.
We first compared the number of heteroplasmies in the par-
ents and offspring, using only those heteroplasmies that had
passed all quality control measures so as not to introduce a bias
when comparing mothers or offspring to fathers. There were sig-
nificantly fewer heteroplasmies in the offspring than in the
parents (P = 0.0179, Mann-Whitney U test), which presumably
reflects the age-related accumulation of heteroplasmies (Liu et al.
1998; Sondheimer et al. 2011; Williams et al. 2013). Indeed, there
is a small but significant correlation between age and number
of heteroplasmies in the parents (Spearman’s rho = 0.139, P =
0.000236). The number of heteroplasmies identified in the off-
spring is significantly correlated with the number of heteroplas-
mies in mothers (rho = 0.328, P = 3 × 10−7), but not with that in
fathers nor with parental age at conception. The number of heter-
oplasmies per individual (using only unrelated individuals, e.g.,
the parents) does not differ significantly from a Poisson distribu-
tion (χ2 test, P = 0.63) (Supplemental Fig. S3), indicating that there
is no evidence to indicate that heteroplasmies occur preferentially
in some individuals; the mean number of heteroplasmies per indi-
vidual was 0.7 (range 0–5). Finally, the MAF distribution across
heteroplasmic sites did not differ significantly between mothers
and fathers (P = 0.10, Mann-Whitney U test).
The average shift in heteroplasmyMAF betweenmothers and
offspring was 0.108 (regardless of direction), with a maximum of
0.787 (Fig. 1). Although the MAF at all heteroplasmic sites did
not differ significantly between mothers and offspring (P = 0.08,
Mann-Whitney U test) (Table 1), the transmitted heteroplasmies
in mothers had a significantly higher MAF than the nontrans-
mitted heteroplasmies (P = 5 × 10−15) (Table 1). Similarly, the in-
herited heteroplasmies in offspring had a significantly higher
MAF than the noninherited (i.e., de novo) heteroplasmies (P =
1 × 10−8) (Table 1), suggesting that heteroplasmies with higher
MAF are more likely to be transmitted to the next generation
and also have a higher mutant allele frequency than de novo mu-
tations (Table 1). Differences in coverage could potentially explain
these results; however, we did not find any significant coverage
differences between transmitted versus nontransmitted hetero-
plasmies in mothers or between inherited versus noninherited
heteroplasmies in offspring (Supplemental Fig. S4).
We observe a higher concordance (i.e., smaller difference in
MAF) in transmitted heteroplasmies in MZ than in DZ twins. For
the 10 sets of MZ twins, the MAF differs significantly between
the members of a twin pair at just one of seven heteroplasmic sites
(Supplemental Table S2), whereas for the eight sets of DZ twins,
the MAF differs significantly at six of nine heteroplasmic sites
(Supplemental Table S3). MZ twins are therefore more concordant
forMAF than are DZ twins, although this result is of borderline sig-
nificance (P = 0.06, Fisher’s exact test).
The major alleles at 18 positions differed between mothers
and offspring (Supplemental Table S6). The biggest changewas ob-
served at np 15152, where the A allele increased from a frequency
of 21.3% in the mother to fixation in the offspring. Interestingly,
the observed G >A mutation at this position is a nonsynonymous
mutation, resulting in a change from Gly to Ser at amino acid po-
sition 136 in theMT-CYB gene. This amino acid change is predict-
ed to have a high risk of a functional effect (Reva et al. 2011) and
has only been reported previously in the Acadian population
(Secher et al. 2014) and in a patient with type 2 diabetes mellitus
(Ohkubo et al. 2000). Only one of the shifts in the major allele
from mother to offspring involved a putative de novo mutation
(i.e., the mutant allele could not be detected in the mother): the
mutant allele at np 8405, which had a frequency of 69.5% in
the offspring (Supplemental Table S6). All the other putative de
novo mutations had a frequency of <30% in the offspring (Fig.
1C). We emphasize that all of these putative de novo mutations
Figure 1. Minor allele frequency (MAF) changes between mothers and offspring. Red arrows indicate cases in which the MAF changed significantly be-
tween mother and offspring (P < 0.00001, Fisher’s exact test). (A) MAF change for heteroplasmies detectable in both mothers and offspring. (B) MAF
change for heteroplasmies detected in offspring but not in mothers. (C) MAF change for heteroplasmies detected in mothers but not in offspring. (D)
Summary of the MAF changes observed for all heteroplasmies.
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could still reflect heteroplasmies that were actually transmitted
from the mothers but were present in the mothers at too low a fre-
quency for our methods to detect. Therefore, these results should
be interpreted as providing an upper bound for the incidence
and frequency shifts of de novo mutations.
The distribution of heteroplasmies across different regions of
the mtDNA genome did not differ among fathers, mothers, and
offspring, but overall heteroplasmies were not distributed at ran-
dom across the mtDNA genome (Fig. 2). Instead, heteroplasmies
occurred preferentially in the noncoding control region (CR), as
observed previously (He et al. 2010; Li et al. 2010; Rebolledo-
Jaramillo et al. 2014; Ye et al. 2014), whereas MT-CO1, MT-ND4,
and tRNAs had fewer heteroplasmies than expected based
on gene length (Fig. 2). The heteroplasmy incidence is signifi-
cantly correlated with the estimated mutation rate for each
site (Pearson’s rho = 0.421, P = 7 × 10−14), as observed previously
(Li et al. 2010), which is in accordance with expectations under
neutrality. However, compared to polymorphisms observed
among the consensus mtDNA genome sequences from the same
individuals, heteroplasmic mutations are enriched for nonsynon-
ymous (NS) mutations relative to synonymous (SS) mutations
(NS:SS ratio is 1.09 for heteroplasmies and 0.46 for polymor-
phisms, P = 2 × 10−6, Fisher’s exact test; the details for each gene
are shown in Fig. 2). Moreover, the NS:SS ratio decreases with in-
creasing MAF (Supplemental Fig. S5), and the proportion of muta-
tions that are predicted to have a high or medium risk of a
functional effect is significantly higher in low frequency (MAF <
5%) than in high frequency (MAF > 5%) heteroplasmies (73% ver-
sus 31%, P = 0.0017, Fisher’s exact test) (Supplemental Fig. S6).
Negative selection
Overall, there is no evidence for nonrandom shift in the MAF (ei-
ther increasing or decreasing) frommother to offspring (P = 0.903,
Wilcoxon signed-rank test). In addition, as shown in Figure 3A,
the average MAF was lower for NS heteroplasmies than for SS or
noncoding (NC) heteroplasmies in both mothers and offspring
(MAF = 0.174 for NS heteroplasmies versus 0.275 for SS-NC heter-
oplasmies in the mothers; MAF = 0.169 for NS heteroplasmies ver-
sus 0.249 for SS-NC heteroplasmies in the offspring). However,
these differences in MAF between NS and SS-NC heteroplasmies
are not significant in either the mothers (P = 0.127, Mann-
WhitneyU test) or the offspring (P = 0.317,Mann-WhitneyU test).
NS heteroplasmic mutations were further categorized, based
on the likelihood of having a functional impact, into high risk,me-
dium risk, low risk, and neutral (Reva et al. 2011). Although high
risk mutations had a lower frequency and were more likely to be
eliminated in the next generation (Fig. 4), the difference between
the high risk and other categories was not significant (P = 0.26).
Overall, these results do not provide compelling evidence for neg-
ative selection against NS mutations during transmission from
mothers to offspring.
However, we do find significant differences in the transmis-
sion of polymorphic heteroplasmies (heteroplasmies for which
both the major and minor alleles have been previously observed
as polymorphic variants in comparisons among mtDNA sequenc-
es fromworldwide individuals) (vanOven and Kayser 2009) versus
novel heteroplasmies (heteroplasmies for which the alleles have
not been reported previously as polymorphic variants). Novel het-
eroplasmies had a significantly lower MAF than polymorphic
heteroplasmies in both mothers (novel MAF: 0.074; polymorphic
MAF: 0.310; P = 0.0001,Mann-WhitneyU test) and offspring (nov-
el MAF: 0.056; polymorphic MAF: 0.286; P = 4 × 10−6). Moreover,
the MAF decreased in frequency from mothers to offspring more
often for novel heteroplasmies than for polymorphic heteroplas-
mies (84.4%of novel heteroplasmies versus 68.0% of polymorphic
heteroplasmies; P = 0.049) (Fig. 5A). Consequently, a significantly
larger proportion of novel heteroplasmies were eliminated in the
offspring (71.1% of novel heteroplasmies versus 27.9% of poly-
morphic heteroplasmies, P = 2.2 × 10−6) (Fig. 5A).
This difference in the disappearance
of novel versus polymorphic hetero-
plasmies remains significant even when
controlling for the lower average MAF
of novel heteroplasmies (Supplemental
Fig. S7). Interestingly, novel heteroplas-
mies are overrepresented in ribosomal
RNA (rRNA) and transfer RNA (tRNA)
genes (Fig. 5B,C): These genes account
for 58% of the novel heteroplasmies
versus just 5% of the polymorphic
heteroplasmies (P = 5 × 10−13, Fisher’s ex-
act test). Moreover, 88% of the novelmu-
tations in rRNA and tRNA genes
decreased in frequency in the offspring,
and 77% disappeared entirely, compared
to 67% of polymorphic mutations in
rRNA and tRNA genes decreasing in
frequency in the offspring and 33%
disappearing entirely. As discussed sub-
sequently, disease-associated mtDNA
mutations often occur in the rRNA/
tRNA genes; these results thus suggest
that negative selection is occurring
against novel heteroplasmies in the
rRNA and tRNA genes that are likely to
be deleterious.
Figure 2. Distribution of heteroplasmies in different mtDNA gene regions. (A) Overall distribution of
heteroplasmies. Black bars represent the expected heteroplasmy frequency for each gene region based
purely on length. Uphill-striped, white, and downhill-striped bars represent the observed proportion of
heteroplasmies identified in fathers, mothers, and offspring, respectively. Gray bars represent the poly-
morphism frequency for each gene region (inferred from PhyloTree Build 15 [van Oven and Kayser
2009]). Asterisks indicate significant differences (P < 0.01) between the observed and expected propor-
tion of heteroplasmy based on gene region length, and the plus signs indicate significant differences be-
tween the observed and expected proportion of heteroplasmy based on polymorphism frequency.
There were no significant differences observed between fathers and mothers, fathers and offspring, or
mothers and offspring in the distribution of heteroplasmies across gene regions. (B) Number of nonsy-
nonymous (NS) and synonymous (SS) heteroplasmies and polymorphisms observed in different genes.
Asterisks indicate that the NS:SS ratio for heteroplasmies is significantly greater than the NS:SS ratio for
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Bottleneck models
We used the distribution of the changes in MAF between mothers
and offspring at heteroplasmic sites (Fig. 1D) to investigate the size
and nature of the transmission bottleneck. We used one offspring
and one heteroplasmic position per family so as to avoid any com-
plications due to potential non-independence of heteroplasmies
within families. The specific positions used are identified in
Supplemental Data Set S1; similar results were obtained when dif-
ferent sets of positions were used. Previous studies of the bottle-
neck size have assumed a constant size for the bottleneck across
individuals and treated each mtDNA genome as an independent
unit (Guo et al. 2013; Rebolledo-Jaramillo et al. 2014); neither var-
iable-size bottleneckmodels nor nucleoidmodels have been inves-
tigated. We therefore fit four models to the data: a constant-size
bottleneck, a variable-size bottleneck, a constant-size bottleneck
with nucleoids, and a variable-size bottleneck with nucleoids
(seeMethods).We took into account the observed coverage and as-
sociated sequencing error rate for each position in the analysis (see
Methods). Under the constant-size bottleneck model, the maxi-
mum-likelihood estimate (MLE) of the number of transmitting
mtDNA genomes was eight (Fig. 6A); and under the variable-size
bottleneck model, the MLE was a mean of nine transmitted
mtDNA genomes (Fig. 6B). For both nucleoid models, we assumed
an average of 7.5 mtDNA genomes per nucleoid, in accordance
with empirical data (Cao et al. 2007; Khrapko 2008; Bogenhagen
2012). The MLE was seven nucleoids for the constant-size bottle-
neck model (Fig. 6C); and for the variable-size bottleneck model,
the MLE was a mean of nine transmitted nucleoids (Fig. 6D). The
Akaike Information Criterion (AIC) for the various models
(Supplemental Table S7) indicates that the variable-size bottleneck
model withmtDNA as independent entities provides the best fit to
the data (the smaller the AIC value, the smaller the loss in informa-
tion when fitting the model).
Discussion
This study of the transmission of human mtDNA heteroplasmy
across the entire mtDNA genome is one of the largest to date and
provides several important insights. However, before discussing
these insights, it is necessary to consider the accuracy of the data.
First, we note that since the GoNL data were originally aligned
and mapped to the hg19 reference, a newer reference (GRChg38)
has become available; remapping the
data to GRCh38 in theory might change
the results. However, the mtDNA refer-
ence sequence has not changed, so the
only difference that could arise would be
in the identificationofNUMTs.We there-
fore did a BLAST search of themtDNAge-
nome against hg19 andGRCh38; there is
a ∼3% increase in the number and total
length of NUMTs in GRCh38 compared
to hg19. Because additional steps are tak-
en in the pipeline to remove potential
NUMT sequences, as discussed in detail
in Li et al. (2012), and the additional con-
firmation by ddPCR indicates that
NUMTs are not being misidentified as
heteroplasmies, it is highly unlikely that
remapping reads toGRCh38would result
in any significant differences in the con-
clusions of our study.
Although next-generation sequencing platforms are extreme-
ly useful for detecting low-level heteroplasmy, rigorous criteria are
needed to call heteroplasmies in order to avoid false positives due
to sequencing errors (Bandelt and Salas 2012). Moreover, contam-
ination with another sample can lead to the false appearance of
heteroplasmy (Just et al. 2014). The pipelinewehave implemented
for calling heteroplasmies includes strict criteria for avoiding false
positives due to sequencing errors, as well as for detecting contam-
ination and avoiding the influence ofNUMTs (Li et al. 2012; Li and
Stoneking 2012). In addition, contamination was previously as-
sessed independently in the GoNL genomic sequence data that
we analyzed (Genome of the Netherlands Consortium 2014).
Most importantly, a subset of the heteroplasmies identified by
our pipeline from the Illumina sequence data were verified by an
independent method (Supplemental Fig. S2; Supplemental Table
S5); it is thus highly unlikely that the heteroplasmies we identified
are sequencing errors, artifacts due to NUMTs, or contamination.
MZ versus DZ twins
We also find fewer heteroplasmies exhibiting significant differenc-
es in MAF in MZ twin pairs than in DZ twin pairs (Supplemental
Figure 3. Frequency of the mutant allele (relative to the revised Cambridge Reference Sequence
[rCRS]) and frequency change of the mutant allele for different mutation types. (A) Frequency of the mu-
tant allele for: NS mutations in the mother [NS(M)]; SS and NCmutations in the mother [SS-NC(M)]; NS
mutations in the offspring [NS(O)]; and SS and NC mutations in the offspring [SS-NC(O)]. (B)
Distribution of the frequency change of NS and SS-NC mutations during transmission from mothers
to offspring. The same results were obtained when the analyses were done for the minor allele at each
position rather than the non-rCRS allele.
Figure 4. Frequency change during transmission for different types of
NS mutations. NS mutations were categorized in terms of likely functional
impact on the protein as high risk, medium risk, low risk, or neutral (Reva
et al. 2011). Other: SS and NC mutations.
Transmission of mtDNA heteroplasmy
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Tables S2, S3), which would not be expected if these reflected se-
quencing errors. This result suggests that for inherited heteroplas-
mies, the MAF in the offspring is largely influenced by the MAF
in the oocyte at the time of fertilization rather than subsequent
drift and/or selectionduringdevelopment.Wenote that a previous
study did not report a higher concordance in heteroplasmy in MZ
versus DZ twin pairs (Andrew et al. 2011); however, this study used
a probe-based assay to interrogate a limited number of positions
in the control region and hence only evaluated the presence/
absence of heteroplasmy at a site, not
the MAF. Another study, which utilized
Sanger sequencing of PCR products of
the control region, did find higher con-
cordance in MAF for MZ than DZ twins
(Bendall et al. 1996). Still, our observa-
tions are based on a relatively small num-
ber of twin pairs (10 MZ and eight DZ),
and therefore need further evaluation in
a larger data set.
Bottleneck models
We used the shifts in heteroplasmy MAF
frommothers to offspring to estimate the
size of the bottleneck that occurs during
the transmission of mtDNA genomes.
The size of the bottleneck was estimated
under four models: a constant-size bot-
tleneck model, in which each mtDNA
genome is a segregating unit and the
bottleneck size does not vary between in-
dividuals; a variable-size bottleneckmod-
el, in which each mtDNA genome is a
segregating unit and the bottleneck size
is allowed to vary between individuals;
a constant-size nucleoidmodel, in which
a nucleoid containing a variable number
of homoplasmic mtDNA genomes is the
segregating unit and the bottleneck size
does not vary between individuals; and
a variable-size nucleoid model, in which
a nucleoid containing a variable number
of homoplasmic mtDNA genomes is the
segregating unit and the bottleneck size
is allowed to vary between individuals.
The best fitting model (as determined
by AIC values) was a variable-size bottle-
neck, with an estimatedmean of nine in-
dividual mtDNA genomes transmitted
from mothers to offspring.
This number is smaller than a recent
estimate of 30–35 mtDNA genomes
transmitted, based on 39 mother-off-
spring pairs (Rebolledo-Jaramillo et al.
2014). Although this previous study as-
sumed a constant-size bottleneck model,
our estimate for a similar constant-size
bottleneck model is also smaller, about
eight mtDNA genomes transmitted (Fig.
6; Supplemental Table S7). The reason
for this discrepancy is probably because
we do not assume that the observed
MAF in the offspring is identical to the MAF at transmission, as
is usually assumed. Instead, we model the replication process
from the bottleneck to the actual mtDNA population in the off-
spring, thereby allowing for genetic drift during the replication
process (see Methods). Doing so allows for substantial changes in
MAF during the replication process, but such changes will only
be substantial if the bottleneck size is small. Incorporating drift
in this way has two consequences: First, the same bottleneckmod-
el can be consistent with the few variants in the data set that have
Figure 5. Transmission characteristics of heteroplasmies for novel versus polymorphic heteroplasmies.
(A) Proportion of minor alleles observed in mothers that disappear entirely, decrease in frequency, or in-
crease in frequency in the offspring for novel versus polymorphic heteroplasmies. (B) Distribution across
genic regions of all heteroplasmies involving novel versus polymorphic heteroplasmies. (C) Distribution
across genic regions for novel heteroplasmies that disappeared in the offspring [Novel(D)] compared to
polymorphic heteroplasmies that disappeared in the offspring [Polymorphic(D)]. TheMT-RNR1 andMT-
RNR2 genes and the tRNA genes are overrepresented in the novel heteroplasmies.
Figure 6. Likelihood curves for the observed data (changes in MAF from mothers to offspring) under
different models for the transmission of mtDNA. (A) Likelihood curve for the constant-size bottleneck
model with mtDNA genomes as segregating units. (B) Likelihood curve for the variable-size bottleneck
model with mtDNA genomes as segregating units. (C) Likelihood curve for the constant-size nucleoid
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drastic changes in allele frequency and with the large set of vari-
ants in the data set that show a smaller change; second, small
MAF in the offspring do not require very large bottleneck sizes.
Consider that without a drift model, the smallest nonzero allele
frequency possible is 1/n, where n is the bottleneck size. Hence,
without modeling drift, all descendants with a very low MAF pro-
vide strong evidence for a large bottleneck size. However, by in-
cluding drift, the final MAF in the offspring can be substantially
smaller than the frequency at the bottleneck. As drift can only
have substantial effects if the bottleneck size is small, this explains
the estimate of a relatively small number of transmitted mtDNA
genomes.
A variable-size bottleneck with eachmtDNA genome as a seg-
regating unit fit the data better than models involving nucleoids.
However, this is not necessarily evidence against nucleoids, as
we assumed an average of 7.5mtDNAgenomes per nucleoid, in ac-
cordance with some observations (Cao et al. 2007; Khrapko 2008;
Bogenhagen 2012). If instead the number of mtDNA genomes per
nucleoid is smaller, then the results based on nucleoids will ap-
proach the results based on mtDNA genomes as segregating units;
in the limit, if each nucleoid contains exactly onemtDNAgenome,
as suggested by some studies (Kukat et al. 2011), then bothmodels
will give identical results. Our results therefore argue against the
existence of nucleoids with several mtDNA genomes, but not nec-
essarily against nucleoids with smaller numbers of mtDNA ge-
nomes. The most important conclusion is that the size of the
bottleneck varies among individuals, whereas all previous at-
tempts to model the size of the bottleneck have assumed that it
is constant among individuals. Identifying the factors that influ-
ence this between-individual variation in bottleneck size would
be of great interest and might have consequences for understand-
ing the transmission of mtDNA-related diseases.
One limitation of our approach is that we are using the MAF
observed in the mother’s blood several years after conception as
the estimate for the MAF in the egg at the time of conception. In
the absenceof data onheteroplasmy inhumaneggs, this limitation
is unavoidable, althoughoneway to improve theestimatewouldbe
to utilize heteroplasmy data from multiple tissues, as was recently
done elsewhere (Rebolledo-Jaramillo et al. 2014). To further
investigate this potential limitation, fromaprevious studyofheter-
oplasmy variation across different tissues (Li et al. 2015), we calcu-
lated the correlation in MAF at heteroplasmic positions in blood
and ovarian tissue from the same individual. There were 52 hetero-
plasmies with MAF > 0.02 detected in either blood or ovarian
tissue (or both) in individuals with data from both tissues, and
the MAF in blood exhibits a modest but nonetheless significant
correlation with that in ovarian tissue (Pearson’s correlation =
0.62, P < 0.0001). Thiswould suggest that theMAF in blood is a rea-
sonable proxy for theMAF in ovarian tissue, although data on het-
eroplasmy in human eggs would still be desirable.
A significant correlation between the mother’s age at con-
ceptionandthenumberofheteroplasmiesdetected in theoffspring
was reportedpreviously (Rebolledo-Jaramillo et al. 2014).However,
there is no such correlation in the GoNL data (Pearson’s rho =
−0.03, P = 0.65), although the range ofmothers’ ages at conception
is similar between the two studies (range = 18–44). The reason for
this difference is unclear, and further studies are warranted.
Negative selection
Our results provide additional insights into the role of negative
selection onheteroplasmic variants.We first examinednonsynon-
ymous (NS) heteroplasmies in the coding region. As found previ-
ously (Li et al. 2010; Ye et al. 2014), NS heteroplasmies occur
proportionally more often (relative to SS heteroplasmies) than do
NS polymorphisms among individuals. Moreover, the ratio of
NS:SS heteroplasmies is higher for low-frequency heteroplasmies
(Supplemental Fig. S5), and low-frequency NS heteroplasmies are
enriched for NS mutations that are likely to have a functional im-
pact (Supplemental Fig. S6). These results are consistent with the
threshold model for deleterious mtDNA mutations (Wallace and
Chalkia 2013): Such mutations are tolerated at a low frequency
within a cell because there are still sufficient nonmutant mtDNA
genomes to carry out normal mitochondrial metabolism. Howev-
er, above a certain frequency threshold, the deleterious mutations
have a negative impact onmitochondrial function and so can nev-
er reach “fixation” within an individual. Thus, NS mutations that
are likely to be deleterious are observed at heteroplasmic frequen-
cies below the frequency threshold, but are never observed as poly-
morphisms (i.e., homoplasmic variants among individuals).
However, we do not see any compelling evidence for negative
selection acting on NS heteroplasmies during transmission from
mothers to offspring. The distribution of the average change in
MAF from mothers to offspring does not differ for NS heteroplas-
mies versus SS-NCheteroplasmies (Fig. 3B). Although there is a ten-
dency forNSheteroplasmieswithahigher riskof a functional effect
to be reduced in frequency or disappear entirely in offspring versus
mothers (Fig. 4), the difference between high-risk versus other
types of NS heteroplasmies is not significant. These results are in
contrast to a previous study (Rebolledo-Jaramillo et al. 2014),
which reported a significant decrease in theMAF for 11 NS hetero-
plasmieswhen comparingmothers to offspring. However, wehave
recomputed (based on a one-tailed sign test) the P-value associated
with the decrease in MAF in this previous study and obtained
a higher value (0.033) than that reported by the authors (9.54 ×
10−7); with Bonferroni correction for multiple tests, this P-value
is no longer significant.Moreover, in this previous study, the chan-
ge in MAF for NS sites does not differ significantly from the MAF
change for SS or NC sites, which we also found to be the case for
the GoNL data. Overall, there does not seem to be any compelling
evidence for selection inhumans againstNSheteroplasmies during
transmission from mothers to offspring.
This conclusion is in contrast with previous studies based on
the mouse mutator mtDNA model (Fan et al. 2008; Stewart et al.
2008a,b), which found evidence for purifying selection against
NS mutations. It may be that the purifying selection in the mouse
mutator model operates at a different level, as the NS mutations
generated in the mouse mutator model may be starting at a
much higher frequency than would be observed in the human
family data, possibly already above the threshold at which an im-
pact on mitochondrial metabolism could occur. Although the dif-
ferences do not reach statistical significance, we do see a tendency
for NS mutations with a higher risk of functional impact to be
reduced in frequency in offspring. Further studies of potential pu-
rifying selection against NS mutations during heteroplasmy trans-
mission in humans are warranted.
In contrast to the situation with NS heteroplasmies, we do
see clear evidence for negative selection acting on heteroplasmies
for novel mutations versus heteroplasmies for polymorphic muta-
tions (Fig. 5). These novel heteroplasmies are enriched for muta-
tions in rRNA and tRNA genes; intriguingly, disease-causing
mtDNA mutations frequently occur in these genes (Taylor and
Turnbull 2005; Tuppen et al. 2010; Wallace and Chalkia 2013).
However, none of the observed rRNA/tRNA heteroplasmies are
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annotated as disease-associated on the MITOMAP website (www.
mitomap.org). Based on criteria developed from conservation of
mitochondrial tRNA sequences across species as well as potential
for disrupting stem–loop pairing (Kondrashov 2005), three of six
novel heteroplasmies and two of three polymorphic heteroplas-
mies are predicted to be deleterious. However, because ∼70% of
tRNA mutations are predicted to be deleterious by these criteria,
it is not clear how to interpret these numbers; further studies are
needed to investigate the functional consequences of these novel
heteroplasmies.
Overall, there is growing evidence for a role of negative selec-
tion in decreasing the frequency of potentially deleterious muta-
tions during the transmission of mtDNA genomes from mothers
to offspring (Fan et al. 2008; Stewart et al. 2008a). This negative se-
lection could operate during the bottleneck that occurs during
transmission of mtDNA from mothers to offspring, as this bottle-
neck might by chance raise the frequency of deleterious hetero-
plasmic mutations above the threshold at which impairment of
mitochondrial function occurs (Freyer et al. 2012). Alternatively,
there may be selective replication favoring nonmutant mtDNA
during the amplification that occurs after the bottleneck, as has
been recently found in Drosophila (Hill et al. 2014). Regardless of
the underlying mechanism, it is important to recognize that neg-
ative selection during the transmission of deleterious heteroplas-
mies is not the same as negative selection against homoplasmic
deleterious mtDNA mutations that reduce fertility or viability;
the latter operates according to the well-known principles of
Darwinian natural selection, whereas the former implies the exis-
tence of a mechanism in the female germ line for recognizing and
preferentially discriminating against such deleterious heteroplas-
mies, perhaps via impaired mitochondrial function (Holt et al.
2014). Understanding how this putative mechanism operates
could be of crucial importance in providing new therapeutic tar-
gets for reducing the transmission of disease-associated mtDNA
mutations.
Methods
The characteristics of the study population and the production
of the sequence data have been described in detail elsewhere
(Boomsma et al. 2014; Genome of the Netherlands Consortium
2014); the sequence data can be accessed at the European
Genome-Phenome Archive (study accession number EGAS000
01000644). Briefly, genomicDNAwas purified fromblood samples
from 769 individuals from across The Netherlands (consisting
of 231 trios, 11 monozygotic [MZ] twin quartets, and eight dizy-
gotic [DZ] twinquartets) and sequenced toanaveragegenomiccov-
erage of∼14× on the IlluminaHiSeq 2000 platform. The readswere
aligned andmapped, and heteroplasmies called (withMAF > 0.02)
as described in detail in the Supplemental Material (Processing
mtDNAdata). A subset of the inferred heteroplasmieswere selected
for independentverificationviadroplet digital PCR,whichwasper-
formed as described previously (Li et al. 2015), with additional de-
tails in the Supplemental Material (Digital Droplet PCR). Potential
contamination in thewhole-genome sequencedatawaspreviously
assessed by the GoNL Consortium (Genome of the Netherlands
Consortium 2014); additional measures were taken to identify
potential contaminationasdescribed in the SupplementalMaterial
(Potential contamination). After removal of potential contami-
nants, there were 756 samples (228 trios, eight DZ twin quartets,
and 10 MZ twin quartets) for further analysis.
The relative mutation rate for each heteroplasmic position
was estimated as the number of mutations observed at that posi-
tion in PhyloTree Build 15 (van Oven and Kayser 2009).
Mutations noted in PhyloTree were defined as polymorphic muta-
tions, whereasmutations that were not reported in PhyloTree were
defined as novel mutations.
The size of the bottleneck during transmission of mtDNA ge-
nomes from mothers to offspring was estimated using a maxi-
mum-likelihood approach for four different models: a constant-
size bottleneck model and a variable-size bottleneck model in
which each mtDNA genome is the segregating unit; and a cons-
tant-size bottleneck model and a variable-size bottleneck model
in which a nucleoid containing a variable number of identical
mtDNA genomes (with mean = 7.5 genomes per nucleoid) is the
segregating unit. The equations used for each model and further
details concerning the modeling approach are in the Supplemen-
tal Material (Estimating the size of the bottleneck during mtDNA
transmission and Modeling the replication process).
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